Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against Trueperella pyogenes in Mice
暂无分享,去创建一个
Ting Huang | Kelei Zhao | Xiuyue Zhang | B. Yue | Tao Song | Yiwen Chu | Xinrong Wang | Xuhao Song
[1] W. Han,et al. vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections , 2021, Frontiers in Microbiology.
[2] T. G. Sumithra,et al. A novel bicistronic DNA vaccine with the enhanced protective immune response against Bacillus anthracis through DNA prime-protein boost vaccination approach. , 2021, Microbial pathogenesis.
[3] Sedef Erkunt Alak,et al. GRA8 DNA vaccine formulations protects against chronic toxoplasmosis. , 2021, Microbial pathogenesis.
[4] Zachary Meili. Trueperella pyogenes pharyngitis in an immunocompetent 40-year-old man , 2020, BMJ Case Reports.
[5] Min Wu,et al. MicroRNA-302/367 Cluster Impacts Host Antimicrobial Defense via Regulation of Mitophagic Response Against Pseudomonas aeruginosa Infection , 2020, Frontiers in Immunology.
[6] S. Boscardin,et al. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. , 2020, Vaccine.
[7] M. Zheng,et al. Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening , 2020, Scientific Reports.
[8] E. Malchiodi,et al. Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi , 2020, Frontiers in Immunology.
[9] Bo Ma,et al. Evaluation of the Potency of Two Pyolysin-Derived Recombinant Proteins as Vaccine Candidates of Trueperella Pyogenes in a Mouse Model: Pyolysin Oligomerization and Structural Change Affect the Efficacy of Pyolysin-Based Vaccines , 2020, Vaccines.
[10] Ting Huang,et al. MTOR involved in bacterial elimination against Trueperella pyogenes infection based on mice model by transcriptome and biochemical analysis. , 2019, Veterinary microbiology.
[11] M. Gieryńska,et al. Pathogenicity and Virulence of Trueperella pyogenes: A Review , 2019, International journal of molecular sciences.
[12] Ting Huang,et al. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection , 2019, Nature Microbiology.
[13] M. Raza,et al. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases , 2018, Biomolecular concepts.
[14] Ting Huang,et al. Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection , 2018, Journal of Nanobiotechnology.
[15] B. Wang,et al. A combined Clostridium perfringens/Trueperella pyogenes inactivated vaccine induces complete immunoprotection in a mouse model. , 2017, Biologicals : journal of the International Association of Biological Standardization.
[16] Chunlian Tian,et al. Trueperella pyogenes isolated from dairy cows with endometritis in Inner Mongolia, China: Tetracycline susceptibility and tetracycline-resistance gene distribution. , 2017, Microbial pathogenesis.
[17] Ting Huang,et al. Comparative transcriptome analysis of Trueperella pyogenes reveals a novel antimicrobial strategy , 2017, Archives of Microbiology.
[18] W. Bielecki,et al. Relationships between antimicrobial resistance, distribution of virulence factor genes and the origin of Trueperella pyogenes isolated from domestic animals and European bison (Bison bonasus). , 2016, Microbial pathogenesis.
[19] Ting Huang,et al. DNA vaccination based on pyolysin co-immunized with IL-1β enhances host antibacterial immunity against Trueperella pyogenes infection. , 2016, Vaccine.
[20] M. Ribeiro,et al. Trueperella pyogenes multispecies infections in domestic animals: a retrospective study of 144 cases (2002 to 2012) , 2015, The Veterinary quarterly.
[21] O. Sandra,et al. Differential Endometrial Cell Sensitivity to a Cholesterol-Dependent Cytolysin Links Trueperella pyogenes to Uterine Disease in Cattle1 , 2014, Biology of reproduction.
[22] Xiaodi Yang,et al. Protective immune response induced by co-immunization with the Trichinella spiralis recombinant Ts87 protein and a Ts87 DNA vaccine. , 2013, Veterinary parasitology.
[23] Hongning Wang,et al. Virulence determinants and biofilm production among Trueperella pyogenes recovered from abscesses of captive forest musk deer , 2013, Archives of Microbiology.
[24] Y. Shao,et al. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant. , 2013 .
[25] H. Lassa,et al. Genotypic characterization and evaluation of an antibiotic resistance of Trueperella pyogenes (Arcanobacterium pyogenes) isolated from milk of dairy cows with clinical mastitis. , 2012, Veterinary microbiology.
[26] A. Ramsay,et al. Prime–boost approaches to tuberculosis vaccine development , 2012, Expert review of vaccines.
[27] Jing Sun,et al. P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant , 2009, Vaccine.
[28] S. J. Billington,et al. Immunization with Genetic Toxoids of the Arcanobacterium pyogenes Cholesterol-Dependent Cytolysin, Pyolysin, Protects Mice against Infection , 2003, Infection and Immunity.
[29] S. J. Billington,et al. Molecular characterization of the pore-forming toxin, pyolysin, a major virulence determinant of Arcanobacterium pyogenes. , 2001, Veterinary microbiology.
[30] J. Gouws,et al. Failure of an Actinomyces pyogenes vaccine to protect sheep against an intravenous challenge. , 1990, The Onderstepoort journal of veterinary research.
[31] Shailza Singh,et al. Cytokine Milieu in Infectious Disease: A Sword or a Boon? , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[32] M. P. Molinari,et al. accine strategies against Babesia bovis based on prime-boost mmunizations in mice with modified vaccinia Ankara vector and ecombinant proteins osé , 2014 .